Antibiotic-producing bacteria from stag beetle mycangia

Area of Science:

• Microbiology
• Drug Discovery
• Insect Symbiosis

Background:

• The increasing threat of infectious diseases necessitates the discovery of new antimicrobial agents.
• Traditional sources like soil bacteria are becoming depleted, driving the search for alternative microbial reservoirs.
• Insect-associated microorganisms represent an underexplored niche for novel bioactive compounds.

Purpose of the Study:

• To investigate the potential of microbial symbionts from stag beetle mycangia as a source of novel antibiotics.
• To isolate and identify bacteria and fungi from the mycangia of three Dorcus beetle species.
• To screen these isolates for antimicrobial activity against pathogenic bacteria and fungi.

Main Methods:

• Isolation of bacterial and fungal strains from the mycangia of Dorcus hopei binodulosus, Dorcus rectus, and Dorcus titanus pilifer.
• Identification of isolates using ribosomal DNA sequencing.
• Culturing of identified strains and collection of culture supernatants.
• Assay of culture supernatants for antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Cryptococcus neoformans.

Main Results:

• Forty strains of bacteria and fungi were successfully isolated from the stag beetle mycangia.
• Klebsiella spp. were identified as the most prevalent symbionts within the mycangia.
• A significant proportion of isolates exhibited antimicrobial activity: 33 against E. coli, 29 against S. aureus, and 18 against C. neoformans.

Conclusions:

• The mycangia of stag beetles harbor a diverse microbial community with considerable potential for antibiotic discovery.
• Klebsiella species from this insect symbiosis are a notable source of antimicrobial compounds.
• These findings highlight insect-associated bacteria as a valuable resource for screening novel antibiotic candidates to combat infectious diseases.